According to a 2002 take a view of...

According to a 2002 take a view of by the Health and Human Services Office of Inspector General, any FDA scientists have doubts about the drug-approval, labeling, and postmarket-monitoring processe Eighteen percent reported being pressur to approve or commend approval of a put drugs into despite reservations about its safety, efficacy, or quality. and nothing else 12% of those individualed were completely confident that FDA's labeling decisions adequately address safety touchs while 30% were only somewhat or